Chunghwa Chemical Synthesis & Biotech Co Ltd Capital Reinvestment Ratio
Chunghwa Chemical Synthesis & Biotech Co Ltd capital reinvestment ratio. Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) has a Capital Reinvestment Ratio of 0.02x as of March 2026, meaning it reinvests 0% of its operating cash flow (NT$90.44 Million) in capital expenditures (NT$1.42 Million). Check 1762 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Chunghwa Chemical Synthesis & Biotech Co Ltd (2008–2025)
Capital reinvestment ratio of Chunghwa Chemical Synthesis & Biotech Co Ltd from 2008 to 2025. This chart tracks Chunghwa Chemical Synthesis & Biotech Co Ltd's Capital Reinvestment Ratio across 17 annual periods. Also explore Chunghwa Chemical Synthesis & Biotech Co (1762) net asset momentum to track the company's year-over-year net asset growth rate.
Chunghwa Chemical Synthesis & Biotech Co Ltd Capital Reinvestment Ratio by Year (2008–2025)
Chunghwa Chemical Synthesis & Biotech Co Ltd capital reinvestment ratio by year from 2008 to 2025. For the full cash flow conversion analysis, see how efficiently does Chunghwa Chemical Synthesis & Biotech Co generate cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.44x | NT$142.61 Million | NT$62.33 Million | ▲ +95.2% |
| 2024 | 0.22x | NT$467.65 Million | NT$104.69 Million | ▼ -56.3% |
| 2022 | 0.51x | NT$733.78 Million | NT$376.18 Million | ▼ -72.3% |
| 2021 | 1.85x | NT$219.18 Million | NT$405.45 Million | ▲ +32.5% |
| 2020 | 1.40x | NT$138.24 Million | NT$192.98 Million | ▲ +226.1% |
| 2019 | 0.43x | NT$268.13 Million | NT$114.80 Million | ▲ +7.2% |
| 2018 | 0.40x | NT$234.66 Million | NT$93.73 Million | ▼ -92.1% |
| 2017 | 5.06x | NT$159.34 Million | NT$805.80 Million | ▲ +1050.6% |
| 2016 | 0.44x | NT$261.31 Million | NT$114.86 Million | ▼ -72.9% |
| 2015 | 1.62x | NT$79.70 Million | NT$129.28 Million | ▼ -74.5% |
| 2014 | 6.35x | NT$23.08 Million | NT$146.59 Million | ▲ +738.2% |
| 2013 | 0.76x | NT$145.24 Million | NT$110.04 Million | ▼ -73.3% |
| 2012 | 2.84x | NT$268.46 Million | NT$762.95 Million | ▲ +513.3% |
| 2011 | 0.46x | NT$144.84 Million | NT$67.12 Million | ▲ +148.0% |
| 2010 | 0.19x | NT$275.61 Million | NT$51.50 Million | ▲ +136.2% |
| 2009 | 0.08x | NT$462.07 Million | NT$36.55 Million | ▼ -85.8% |
| 2008 | 0.56x | NT$75.39 Million | NT$42.12 Million | — |